Fabre-Kramer Pharmaceuticals

Fabre Kramer Pharmaceuticals

Mental Health Care, 5847 San Felipe St, Houston, Texas, 77057, United States, 1-10 Employees

fabrekramer.com

  • LinkedIn

phone no Phone Number: 71********

Who is FABRE-KRAMER PHARMACEUTICALS

Fabre-Kramer Pharmaceuticals, Inc., is a pharmaceutical company which identifies, develops and commercializes psychotropic drugs. The Companys principals have over 40 years of experience ...

Read More

map

industries-icon Industry: Mental Health Care

SIC SIC Code: 2834 | NAICS Code: 541110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from FABRE-KRAMER PHARMACEUTICALS

Fabre-Kramer Pharmaceuticals Org Chart and Mapping

Employees

Stephen Kramer

Chief Executive Officer

Palak K

Sr. Clinical Business Analyst

Jennifer Spring

Project Manager - Neuroscience Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Fabre-Kramer Pharmaceuticals

Answer: Fabre-Kramer Pharmaceuticals's headquarters are located at 5847 San Felipe St, Houston, Texas, 77057, United States

Answer: Fabre-Kramer Pharmaceuticals's phone number is 71********

Answer: Fabre-Kramer Pharmaceuticals's official website is https://fabrekramer.com

Answer: Fabre-Kramer Pharmaceuticals's revenue is $1 Million to $5 Million

Answer: Fabre-Kramer Pharmaceuticals's SIC: 2834

Answer: Fabre-Kramer Pharmaceuticals's NAICS: 541110

Answer: Fabre-Kramer Pharmaceuticals has 1-10 employees

Answer: Fabre-Kramer Pharmaceuticals is in Mental Health Care

Answer: Fabre-Kramer Pharmaceuticals contact info: Phone number: 71******** Website: https://fabrekramer.com

Answer: Fabre-Kramer Pharmaceuticals, Inc., is a pharmaceutical company which identifies, develops and commercializes psychotropic drugs. The Companys principals have over 40 years of experience in the clinical development of psychotropic drugs and have conducted pivotal studies of many drugs approved by the FDA in psychiatry. They have conducted studies in depression, anxiety, schizophrenia, bipolar disorder, social phobia and sleep disorders. They also have over 40 years of experience in in-patient and out-patient psychiatry, have intimate knowledge of the treatment of Central Nervous System disorders and have analyzed many potential psychotropic compounds from the standpoint of receptor activity, efficacy, tolerability, side effect/benefit ratio, formulation, ease of administration, cost, and ease of manufacturing. At Fabre-Kramer Pharmaceuticals, our goal is to develop and bring to market advanced new medications to help physicians treat their patients unmet medical needs. The Company is in an excellent position to identify and acquire promising psychotropic drugs that, for a variety of reasons, are available from major pharmaceutical companies and other industry and academic sources.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access